Here are five notes:
1. The shares were sold at an average price of $22.37, for a total of $12.8 million.
2. After the transaction, the director now owns 440 shares of the company’s stock, valued at approximately $9,842.
3. K2M has a 52-week low of $12.31 and a 52-week high of $26.29.
4. The stock has a 50-day moving average of $24.40 and a 200-day moving average of $22.23.
5. The company’s market cap is $954.50 million.
More articles on devices:
NuVasive names new executive vice president — 5 key notes
J&J Orthopedics sales drop 5.6% in Q2: 5 key notes
Surgical Science features Zyga’s SImmetry SI joint fusion system: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
